Keros Therapeutics
Christopher Simmons currently serves as a Clinical Trial Associate at Keros Therapeutics since May 2024. Prior to this role, Christopher held multiple positions at Dana-Farber Cancer Institute from June 2018 to May 2024, including Senior Clinical Research Coordinator and various roles within the Immune Effector Cell Program and the Center for Cutaneous Oncology. Christopher graduated from the College of the Holy Cross in 2018.
This person is not in any teams
This person is not in any offices